{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:15:49Z","timestamp":1790727349579,"version":"4.1.0"},"reference-count":86,"publisher":"American Society for Microbiology","issue":"23","license":[{"start":{"date-parts":[[2015,11,5]],"date-time":"2015-11-05T00:00:00Z","timestamp":1446681600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/3.0\/"},{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["J Virol"],"published-print":{"date-parts":[[2015,12]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>\n            Adult T cell leukemia\/lymphoma (ATL) is an aggressive cancer of CD4\/CD25\n            <jats:sup>+<\/jats:sup>\n            T lymphocytes, the etiological agent of which is human T-cell lymphotropic virus type 1 (HTLV-1). ATL is highly refractory to current therapies, making the development of new treatments a high priority. Oncolytic viruses such as vesicular stomatitis virus (VSV) are being considered as anticancer agents since they readily infect transformed cells compared to normal cells, the former appearing to exhibit defective innate immune responses. Here, we have evaluated the efficacy and safety of a recombinant VSV that has been retargeted to specifically infect and replicate in transformed CD4\n            <jats:sup>+<\/jats:sup>\n            cells. This was achieved by replacing the single VSV glycoprotein (G) with human immunodeficiency virus type 1 (HIV-1) gp160 to create a hybrid fusion protein, gp160G. The resultant virus, VSV-gp160G, was found to only target cells expressing CD4 and retained robust oncolytic activity against HTLV-1 actuated ATL cells. VSV-gp160G was further noted to be highly attenuated and did not replicate efficiently in or induce significant cell death of primary CD4\n            <jats:sup>+<\/jats:sup>\n            T cells. Accordingly, VSV-gp160G did not elicit any evidence of neurotoxicity even in severely immunocompromised animals such as NOD\/Shi-scid, IL-2R\u03b3-c-null (NSG) mice. Importantly, VSV-gp160G effectively exerted potent oncolytic activity in patient-derived ATL transplanted into NSG mice and facilitated a significant survival benefit. Our data indicate that VSV-gp160G exerts potent oncolytic efficacy against CD4\n            <jats:sup>+<\/jats:sup>\n            malignant cells and either alone or in conjunction with established therapies may provide an effective treatment in patients displaying ATL.\n          <\/jats:p>\n          <jats:p>\n            <jats:bold>IMPORTANCE<\/jats:bold>\n            Adult T cell leukemia (ATL) is a serious form of cancer with a high mortality rate. HTLV-1 infection is the etiological agent of ATL and, unfortunately, most patients succumb to the disease within a few years. Current treatment options have failed to significantly improve survival rate. In this study, we developed a recombinant strain of vesicular stomatitis virus (VSV) that specifically targets transformed CD4\n            <jats:sup>+<\/jats:sup>\n            T cells through replacement of the G protein of VSV with a hybrid fusion protein, combining domains from gp160 of HIV-1 and VSV-G. This modification eliminated the normally broad tropism of VSV and restricted infection to primarily the transformed CD4\n            <jats:sup>+<\/jats:sup>\n            cell population. This effect greatly reduced neurotoxic risk associated with VSV infection while still allowing VSV to effectively target ATL cells.\n          <\/jats:p>","DOI":"10.1128\/jvi.01356-15","type":"journal-article","created":{"date-parts":[[2015,9,17]],"date-time":"2015-09-17T03:38:17Z","timestamp":1442461097000},"page":"11786-11800","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":24,"title":["Retargeting Oncolytic Vesicular Stomatitis Virus to Human T-Cell Lymphotropic Virus Type 1-Associated Adult T-Cell Leukemia"],"prefix":"10.1128","volume":"89","author":[{"given":"Dillon","family":"Betancourt","sequence":"first","affiliation":[{"name":"Department of Microbiology and Immunology, University of Miami School of Medicine, Miami, Florida, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Carlos","family":"Ramos","sequence":"additional","affiliation":[{"name":"Department of Medicine and Sylvester Comprehensive Cancer Center, University of Miami School of Medicine, Miami, Florida, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glen N.","family":"Barber","sequence":"additional","affiliation":[{"name":"Department of Cell Biology, University of Miami School of Medicine, Miami, Florida, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.beha.2013.04.001"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.41.6.2593-2595.2003"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1208968"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.1994.tb01297.x"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.1980030304"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0215(20000201)85:3<319::AID-IJC4>3.0.CO;2-B"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1991.tb08051.x"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11899-007-0035-x"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(04)01608-0"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19950401)75:7<1598::AID-CNCR2820750708>3.0.CO;2-7"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2004.04956.x"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.3960\/jslrt.43.43"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00887-07"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2007.12.036"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2010.537"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2012.00406"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M307275200"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M802527200"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-11-189845"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1186\/1742-4690-5-100"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.179.8.5082"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0900707"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0605298103"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.19.1.475"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/0966-842X(93)90127-D"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1460-2075.1986.tb04583.x"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-2478(93)90026-X"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1128\/mcb.8.12.5581-5587.1988"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.172.1.121"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.68.11.7275-7283.1994"},{"key":"e_1_3_2_32_2","doi-asserted-by":"crossref","unstructured":"Fujii M Sassone-Corsi P Verma IM. 1988. c-fos promoter trans-activation by the tax1 protein of human T-cell leukemia virus type I Proc Natl Acad Sci U S A 85:8526\u20138530.","DOI":"10.1073\/pnas.85.22.8526"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.66.7.4570-4575.1992"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V86.10.3619.bloodjournal86103619"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1209055"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1007\/s13238-012-2047-0"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V50.3.481.481"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/101754"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.2287"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1089\/vim.2004.17.516"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1114981109"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.77.16.8843-8856.2003"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.67.1.360-365.1993"},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.71.7.5060-5068.1997"},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2001-12-0207"},{"key":"e_1_3_2_46_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.92.10.4477"},{"key":"e_1_3_2_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jviromet.2010.08.006"},{"key":"e_1_3_2_48_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-61779-340-0_10"},{"key":"e_1_3_2_49_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.76.1.19-31.2002"},{"key":"e_1_3_2_50_2","doi-asserted-by":"publisher","DOI":"10.1099\/vir.0.046672-0"},{"key":"e_1_3_2_51_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.77.9.5524-5528.2003"},{"key":"e_1_3_2_52_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jviromet.2003.08.016"},{"key":"e_1_3_2_53_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-4157(00)00014-9"},{"key":"e_1_3_2_54_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2005.01.009"},{"key":"e_1_3_2_55_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(01)00482-2"},{"key":"e_1_3_2_56_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02601-07"},{"key":"e_1_3_2_57_2","first-page":"423","volume-title":"Hepatitis C viruses: genomes and molecular biology","author":"Majid AM","year":"2006","unstructured":"Majid AM, Barber GN. 2006. Recombinant vesicular stomatitis virus (VSV) and other strategies in HCV vaccine designs and immunotherapy, p 423\u2013450. In Tan SL (ed), Hepatitis C viruses: genomes and molecular biology. Horizon Bioscience, Norfolk, United Kingdom."},{"key":"e_1_3_2_58_2","doi-asserted-by":"publisher","DOI":"10.1128\/mr.59.1.63-93.1995"},{"key":"e_1_3_2_59_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.64.11.5403-5411.1990"},{"key":"e_1_3_2_60_2","doi-asserted-by":"publisher","DOI":"10.3390\/v2061306"},{"key":"e_1_3_2_61_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.cgt.7700071"},{"key":"e_1_3_2_62_2","first-page":"2306","article-title":"Potent systemic antitumor activity from an oncolytic herpes simplex virus of syncytial phenotype","volume":"62","author":"Fu X","year":"2002","unstructured":"Fu X, Zhang X. 2002. Potent systemic antitumor activity from an oncolytic herpes simplex virus of syncytial phenotype. Cancer Res 62:2306\u20132312.","journal-title":"Cancer Res"},{"key":"e_1_3_2_63_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-03-3753"},{"key":"e_1_3_2_64_2","first-page":"6396","article-title":"Viral fusogenic membrane glycoprotein expression causes syncytium formation with bioenergetic cell death: implications for gene therapy","volume":"60","author":"Higuchi H","year":"2000","unstructured":"Higuchi H, Bronk SF, Bateman A, Harrington K, Vile RG, Gores GJ. 2000. Viral fusogenic membrane glycoprotein expression causes syncytium formation with bioenergetic cell death: implications for gene therapy. Cancer Res 60:6396\u20136402.","journal-title":"Cancer Res"},{"key":"e_1_3_2_65_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm0598-581"},{"key":"e_1_3_2_66_2","first-page":"6566","article-title":"Viral fusogenic membrane glycoproteins kill solid tumor cells by nonapoptotic mechanisms that promote cross presentation of tumor antigens by dendritic cells","volume":"62","author":"Bateman AR","year":"2002","unstructured":"Bateman AR, Harrington KJ, Kottke T, Ahmed A, Melcher AA, Gough MJ, Linardakis E, Riddle D, Dietz A, Lohse CM, Strome S, Peterson T, Simari R, Vile RG. 2002. Viral fusogenic membrane glycoproteins kill solid tumor cells by nonapoptotic mechanisms that promote cross presentation of tumor antigens by dendritic cells. Cancer Res 62:6566\u20136578.","journal-title":"Cancer Res"},{"key":"e_1_3_2_67_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.gt.3301277"},{"key":"e_1_3_2_68_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1525-0016(03)00092-3"},{"key":"e_1_3_2_69_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0800596"},{"key":"e_1_3_2_70_2","doi-asserted-by":"publisher","DOI":"10.1080\/713803696"},{"key":"e_1_3_2_71_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.virusres.2014.05.025"},{"key":"e_1_3_2_72_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.74.23.10903-10910.2000"},{"key":"e_1_3_2_73_2","first-page":"175","article-title":"The role of antibodies in natural and acquired resistance of mice to vesicular stomatitis virus","volume":"56","author":"Gobet R","year":"1988","unstructured":"Gobet R, Cerny A, Ruedi E, Hengartner H, Zinkernagel RM. 1988. The role of antibodies in natural and acquired resistance of mice to vesicular stomatitis virus. Exp Cell Biol 56:175\u2013180.","journal-title":"Exp Cell Biol"},{"key":"e_1_3_2_74_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1209042"},{"key":"e_1_3_2_75_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00142-06"},{"key":"e_1_3_2_76_2","first-page":"8366","article-title":"The oncolytic effect of recombinant vesicular stomatitis virus is enhanced by expression of the fusion cytosine deaminase\/uracil phosphoribosyltransferase suicide gene","volume":"63","author":"Porosnicu M","year":"2003","unstructured":"Porosnicu M, Mian A, Barber GN. 2003. The oncolytic effect of recombinant vesicular stomatitis virus is enhanced by expression of the fusion cytosine deaminase\/uracil phosphoribosyltransferase suicide gene. Cancer Res 63:8366\u20138376.","journal-title":"Cancer Res"},{"key":"e_1_3_2_77_2","doi-asserted-by":"publisher","DOI":"10.1038\/gt.2010.66"},{"key":"e_1_3_2_78_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.cgt.7700835"},{"key":"e_1_3_2_79_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2011.05.078"},{"key":"e_1_3_2_80_2","doi-asserted-by":"publisher","DOI":"10.1269\/jrr.10185"},{"key":"e_1_3_2_81_2","doi-asserted-by":"publisher","DOI":"10.1089\/10430340050016166"},{"key":"e_1_3_2_82_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-07-1306"},{"key":"e_1_3_2_83_2","doi-asserted-by":"publisher","DOI":"10.1038\/cgt.2008.90"},{"key":"e_1_3_2_84_2","doi-asserted-by":"publisher","DOI":"10.4161\/onci.28694"},{"key":"e_1_3_2_85_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.exphem.2006.06.010"},{"key":"e_1_3_2_86_2","doi-asserted-by":"publisher","DOI":"10.1186\/1742-4690-2-27"},{"key":"e_1_3_2_87_2","doi-asserted-by":"publisher","DOI":"10.1186\/1742-4690-11-S1-P43"}],"container-title":["Journal of Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JVI.01356-15","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JVI.01356-15","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,5]],"date-time":"2022-03-05T14:04:53Z","timestamp":1646489093000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/JVI.01356-15"}},"subtitle":[],"editor":[{"given":"S. R.","family":"Ross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":86,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["10.1128\/JVI.01356-15"],"URL":"https:\/\/doi.org\/10.1128\/jvi.01356-15","relation":{},"ISSN":["0022-538X","1098-5514"],"issn-type":[{"value":"0022-538X","type":"print"},{"value":"1098-5514","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"2015-05-26","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2015-08-18","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2015-11-05","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}